ASTEX PHARMACEUTICALS, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2011-01-01
- Employees
- 136
- Market Cap
- -
- Website
- http://www.astx.com
Clinical Trials
104
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (97 trials with phase data)• Click on a phase to view related trials
A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
- Conditions
- Myelodysplastic Syndromes
- Interventions
- First Posted Date
- 2023-04-28
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Astex Pharmaceuticals, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT05835011
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸BRCR Medical Center, Plantation, Florida, United States
🇺🇸Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Thorough QT Assessment of Cedazuridine in Healthy Subjects
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Astex Pharmaceuticals, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT04953923
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyeloproliferative Neoplasm
- Interventions
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Astex Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04637009
- Locations
- 🇺🇸
University of Alabama - Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸University of Southern California Keck School of Medicine, Los Angeles, California, United States
Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Astex Pharmaceuticals, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT04479800
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
A Phase 1 Study to Evaluate the Effect of Food on Pharmacokinetics of ASTX029
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Astex Pharmaceuticals, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT04466514
- Locations
- 🇺🇸
Frontage Clinical Services, Secaucus, New Jersey, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next